Class information for:
Level 1: RISK MANAGEMENT STRATEGY//PHARMACOVIGILANCE//MEDDRA

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
9803 1054 27.4 65%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
1105 9279 BEERS CRITERIA//PHARMACOVIGILANCE//MEDICATION RECONCILIATION

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 RISK MANAGEMENT STRATEGY Address 29 88% 1% 14
2 PHARMACOVIGILANCE Author keyword 21 14% 14% 143
3 MEDDRA Author keyword 15 63% 1% 15
4 PROPORTIONAL REPORTING RATIO Author keyword 14 100% 1% 7
5 LESIM Address 11 69% 1% 9
6 UPPSALA MONITORING Address 10 42% 2% 18
7 OBSERVAT MED OUTCOMES PARTNERSHIP Address 9 83% 0% 5
8 EU ADR Author keyword 8 100% 0% 5
9 MINI SENTINEL Author keyword 7 64% 1% 7
10 DISPROPORTIONALITY ANALYSIS Author keyword 7 53% 1% 9

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 PHARMACOVIGILANCE 21 14% 14% 143 Search PHARMACOVIGILANCE Search PHARMACOVIGILANCE
2 MEDDRA 15 63% 1% 15 Search MEDDRA Search MEDDRA
3 PROPORTIONAL REPORTING RATIO 14 100% 1% 7 Search PROPORTIONAL+REPORTING+RATIO Search PROPORTIONAL+REPORTING+RATIO
4 EU ADR 8 100% 0% 5 Search EU+ADR Search EU+ADR
5 MINI SENTINEL 7 64% 1% 7 Search MINI+SENTINEL Search MINI+SENTINEL
6 DISPROPORTIONALITY ANALYSIS 7 53% 1% 9 Search DISPROPORTIONALITY+ANALYSIS Search DISPROPORTIONALITY+ANALYSIS
7 FAERS 7 57% 1% 8 Search FAERS Search FAERS
8 SELF CONTROLLED CASE SERIES 7 41% 1% 13 Search SELF+CONTROLLED+CASE+SERIES Search SELF+CONTROLLED+CASE+SERIES
9 REPORTING ODDS RATIO 6 58% 1% 7 Search REPORTING+ODDS+RATIO Search REPORTING+ODDS+RATIO
10 VACCINE SAFETY 6 13% 4% 41 Search VACCINE+SAFETY Search VACCINE+SAFETY

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 PHARMACOVIGILANCE 83 38% 16% 172
2 MEDICAL OUTCOMES PARTNERSHIP 29 88% 1% 14
3 HEALTH CARE DATA 21 90% 1% 9
4 DISPROPORTIONALITY 18 34% 4% 44
5 SIGNAL GENERATION 17 25% 6% 61
6 VACCINE SAFETY 13 41% 2% 24
7 REAL TIME SURVEILLANCE 12 75% 1% 9
8 LARGE FREQUENCY TABLES 12 63% 1% 12
9 MEDICAL DICTIONARY 11 65% 1% 11
10 SPONTANEOUS REPORTING SYSTEM 11 45% 2% 19

Journals

Reviews



Title Publ. year Cit. Active
references
% act. ref.
to same field
Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how? 2014 9 22 68%
Quantitative signal detection using spontaneous ADR reporting 2009 116 55 84%
Data Mining of the Public Version of the FDA Adverse Event Reporting System 2013 24 75 56%
Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis 2012 45 43 63%
Improving Postapproval Drug Safety Surveillance: Getting Better Information Sooner 2015 1 44 25%
Should we use a case-crossover design? 2000 263 40 33%
Pharmacovigilance: methods, recent developments and future perspectives 2008 64 25 40%
Postmarketing Safety Surveillance Where does Signal Detection Using Electronic Healthcare Records Fit into the Big Picture? 2013 8 61 61%
Decision support methods for the detection of adverse events in post-marketing data 2009 42 47 72%
The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database 2008 19 36 75%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 RISK MANAGEMENT STRATEGY 29 88% 1.3% 14
2 LESIM 11 69% 0.9% 9
3 UPPSALA MONITORING 10 42% 1.7% 18
4 OBSERVAT MED OUTCOMES PARTNERSHIP 9 83% 0.5% 5
5 IMMUNIZAT SAFETY OFF 4 15% 2.6% 27
6 INFORMAT COMP MATH 4 75% 0.3% 3
7 INTEGRAT EDUC PHARM PHARMACEUT SCI 4 50% 0.6% 6
8 WHO ABORATING INT DRUG MONITORING 4 46% 0.6% 6
9 POST LICENSING 3 50% 0.5% 5
10 OFF BIOSTAT EPIDEMIOL 3 15% 2.0% 21

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000216110 PHARMACOVIGILANCE//ADVERSE DRUG REACTIONS//ADR REPORTING
2 0.0000100783 JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION//CLINICAL TEXT//MEDICAL LANGUAGE PROCESSING
3 0.0000093959 ACTIVATION SYNDROME//RISK EVALUATION AND MITIGATION STRATEGIES//REGULATORY ACTIONS
4 0.0000068105 HOSPITAL CONTROLS//BERKSONS BIAS//CHOICE OF CONTROLS
5 0.0000048844 BLEEDING ABNORMALITIES//VENOUS THROMBOSIS AND EMBOLISM//ABORATING TRAINING PHARMACOEPIDEMIO
6 0.0000048048 SUSPECTED ADVERSE DRUG REACTIONS//VET PHARMACOVIGILANCE MED INFORMAT//VETERINARY PHARMACOVIGILANCE
7 0.0000048003 PROPENSITY SCORE//MATCHED SAMPLING//UNCONFOUNDEDNESS
8 0.0000045257 ICES UOTTAWA//VACCINATION AGE//TUBERCULIN RESPONSE
9 0.0000042310 POLYPHARMACOLOGY//NETWORK PHARMACOLOGY//DRUG REPOSITIONING
10 0.0000041281 DRUG LAG//OFF PHARMACEUT IND//JAPANESE CLINICAL TRIALS